Multivariate analysis showed that the LAT1-positive group and T factor were independently associated with recurrence in CRC patients treated with adjuvant chemotherapy (hazard ratio (HR), 3.99; 95% confidence interval (CI), 1.327–11.99; p = 0.014, HR, 3.28; 95% CI, 1.309–8.234; p = 0.011, respectively (Table 2). This evidence concerns the gene LAT and colorectal carcinoma.